Home POZEN Rating Increased to Buy at Ascendiant Capital Markets
 

Keywords :   


POZEN Rating Increased to Buy at Ascendiant Capital Markets

2014-08-09 22:40:07| Biotech - Topix.net

The firm currently has a $10.00 price target on the stock. Ascendiant Capital Markets' price target would suggest a potential upside of 22.25% from the company's current price.

Tags: buy rating capital increased

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 10
28.09Hurricane Isaac Wind Speed Probabilities Number 10
28.09Hurricane Isaac Public Advisory Number 10
28.09Summary for Hurricane Isaac (AT5/AL102024)
28.09Hurricane Isaac Forecast Advisory Number 10
More »